IT8349355A0 - Uso terapeutico della fosfatidilserina in malattie del sistema nervoso centrale senza effetti sulla coagulazione sanguigna - Google Patents

Uso terapeutico della fosfatidilserina in malattie del sistema nervoso centrale senza effetti sulla coagulazione sanguigna

Info

Publication number
IT8349355A0
IT8349355A0 IT8349355A IT4935583A IT8349355A0 IT 8349355 A0 IT8349355 A0 IT 8349355A0 IT 8349355 A IT8349355 A IT 8349355A IT 4935583 A IT4935583 A IT 4935583A IT 8349355 A0 IT8349355 A0 IT 8349355A0
Authority
IT
Italy
Prior art keywords
phosphatidylserine
effects
nervous system
central nervous
therapeutic use
Prior art date
Application number
IT8349355A
Other languages
English (en)
Other versions
IT1212900B (it
Inventor
Della Valle Francesco
Romeo Aurelio
Original Assignee
Della Valle Francesco
Romeo Aurelio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Della Valle Francesco, Romeo Aurelio filed Critical Della Valle Francesco
Publication of IT8349355A0 publication Critical patent/IT8349355A0/it
Priority to IT49355/83A priority Critical patent/IT1212900B/it
Priority to US06/599,341 priority patent/US4595680A/en
Priority to IE278584A priority patent/IE58130B1/en
Priority to DK524884A priority patent/DK168271B1/da
Priority to NZ210091A priority patent/NZ210091A/xx
Priority to IN767/CAL/84A priority patent/IN162717B/en
Priority to IL73420A priority patent/IL73420A/xx
Priority to ZA848776A priority patent/ZA848776B/xx
Priority to ES537575A priority patent/ES8608528A1/es
Priority to LU85639A priority patent/LU85639A1/fr
Priority to FR8417262A priority patent/FR2555050B1/fr
Priority to FI844468A priority patent/FI79946C/fi
Priority to GR80951A priority patent/GR80951B/el
Priority to CH5471/84A priority patent/CH661734A5/fr
Priority to JP59242174A priority patent/JPH0676334B2/ja
Priority to MX203403A priority patent/MX160792A/es
Priority to AT84402340T priority patent/ATE35415T1/de
Priority to AU35630/84A priority patent/AU572228B2/en
Priority to HU844269A priority patent/HU193302B/hu
Priority to DE8484402340T priority patent/DE3472406D1/de
Priority to PT79510A priority patent/PT79510B/pt
Priority to NO844585A priority patent/NO164275C/no
Priority to EP84402340A priority patent/EP0148045B1/en
Priority to BE0/214020A priority patent/BE901074A/nl
Priority to KR1019840007230A priority patent/KR870001330B1/ko
Application granted granted Critical
Publication of IT1212900B publication Critical patent/IT1212900B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J7/00—Phosphatide compositions for foodstuffs, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Dispersion Chemistry (AREA)
  • Neurology (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heat Treatment Of Steel (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Epoxy Resins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IT49355/83A 1983-11-17 1983-11-17 Uso terapeutico della fosfatidilserina in malattie del sistema nervoso centrale senza effetti sulla coagulazione sanguigna IT1212900B (it)

Priority Applications (25)

Application Number Priority Date Filing Date Title
IT49355/83A IT1212900B (it) 1983-11-17 1983-11-17 Uso terapeutico della fosfatidilserina in malattie del sistema nervoso centrale senza effetti sulla coagulazione sanguigna
US06/599,341 US4595680A (en) 1983-11-17 1984-04-12 Pharmaceutical compositions and method for preparing phosphatidylserine compositions useful in treating central nervous system disorders without effects on blood coagulation
IE278584A IE58130B1 (en) 1983-11-17 1984-10-30 Pharmaceutical compositions and method for preparing phosphatidylserine compositions useful in treating central nervous system disorders without effects on blood coagulation
DK524884A DK168271B1 (da) 1983-11-17 1984-11-02 Farmaceutiske præparater indeholdende phosphatidylserin og fremgangsmåde til fremstilling deraf
NZ210091A NZ210091A (en) 1983-11-17 1984-11-02 Phosphatidylserine compositions and their preparation
IN767/CAL/84A IN162717B (it) 1983-11-17 1984-11-02
IL73420A IL73420A (en) 1983-11-17 1984-11-05 Phosphatidylserine and phosphatidylethanol amine compositions for treating central nervous system disorders
ZA848776A ZA848776B (en) 1983-11-17 1984-11-09 Pharmaceutical compositions and method for preparing phosphatidylserine compositions useful in treating central nervous system disorders without effects on blood coagulation
ES537575A ES8608528A1 (es) 1983-11-17 1984-11-12 Procedimiento para la fabricacion de fosfatidilserina para el tratamiento de desordenes del sistema nervioso central
LU85639A LU85639A1 (fr) 1983-11-17 1984-11-13 Compositions pharmaceutiques et procede de preparation de compositions de phosphatidylserine utilisables au traitement de desordres du systeme nerveux central sans exercer d'effets sur la coagulation du sang
FR8417262A FR2555050B1 (fr) 1983-11-17 1984-11-13 Compositions pharmaceutiques et procede de preparation de compositions de phosphatidylserine, utilisables au traitement de desordres du systeme nerveux central sans exercer d'effets sur la coagulation du sang
FI844468A FI79946C (fi) 1983-11-17 1984-11-14 Foerfarande foer framstaellning av fosfolipid-sammansaettning anvaendbara vid behandling av sjukdomar i det centrala nervsystemet.
GR80951A GR80951B (en) 1983-11-17 1984-11-15 Pharmaceutical compositions and method for preparing phosphatidylserine compositions useful in treating central nervous system disorders without effects on blood coagulation
CH5471/84A CH661734A5 (fr) 1983-11-17 1984-11-15 Procede de preparation de compositions de phospholipides utilisables au traitement de desordres du systeme nerveux central sans exercer d'effets sur la coagulation du sang.
JP59242174A JPH0676334B2 (ja) 1983-11-17 1984-11-15 ホスファチジルセリン医薬組成物
MX203403A MX160792A (es) 1983-11-17 1984-11-15 Metodo mejorado para la preparacion de una composicion de fosfolipidos
DE8484402340T DE3472406D1 (en) 1983-11-17 1984-11-16 Pharmaceutical compositions and method for preparing phosphatidylserine compositions useful in treating central nervous system disorders without effects on blood coagulation
AU35630/84A AU572228B2 (en) 1983-11-17 1984-11-16 Phosphatidyl serine compositions for cns disorders
HU844269A HU193302B (en) 1983-11-17 1984-11-16 Process for producing phospholipide compositions and pharmaceutical compositions containing them as active agents
AT84402340T ATE35415T1 (de) 1983-11-17 1984-11-16 Pharmazeutische zusammensetzungen und verfahren fuer die herstellung von zusammensetzungen mit gehalt an phosphatidylserine zur behandlung von stoerungen des centralen nervensystems ohne wirkungen auf die blutkoagulation.
PT79510A PT79510B (en) 1983-11-17 1984-11-16 Phosphatidylserine compositions
NO844585A NO164275C (no) 1983-11-17 1984-11-16 Fremgangsmaate for fremstilling av et fosfolipid-preparat.
EP84402340A EP0148045B1 (en) 1983-11-17 1984-11-16 Pharmaceutical compositions and method for preparing phosphatidylserine compositions useful in treating central nervous system disorders without effects on blood coagulation
BE0/214020A BE901074A (nl) 1983-11-17 1984-11-16 Compositions pharmaceutiques et procede de preparation de compositions de phosphatidylserine utilisables au traitement de desordres du systeme nerveux central sans exercer d'effets sur la coagulation du sang.
KR1019840007230A KR870001330B1 (ko) 1983-11-17 1984-11-17 포스포리피드 조성물의 제조방법

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT49355/83A IT1212900B (it) 1983-11-17 1983-11-17 Uso terapeutico della fosfatidilserina in malattie del sistema nervoso centrale senza effetti sulla coagulazione sanguigna

Publications (2)

Publication Number Publication Date
IT8349355A0 true IT8349355A0 (it) 1983-11-17
IT1212900B IT1212900B (it) 1989-11-30

Family

ID=11270453

Family Applications (1)

Application Number Title Priority Date Filing Date
IT49355/83A IT1212900B (it) 1983-11-17 1983-11-17 Uso terapeutico della fosfatidilserina in malattie del sistema nervoso centrale senza effetti sulla coagulazione sanguigna

Country Status (25)

Country Link
US (1) US4595680A (it)
EP (1) EP0148045B1 (it)
JP (1) JPH0676334B2 (it)
KR (1) KR870001330B1 (it)
AT (1) ATE35415T1 (it)
AU (1) AU572228B2 (it)
BE (1) BE901074A (it)
CH (1) CH661734A5 (it)
DE (1) DE3472406D1 (it)
DK (1) DK168271B1 (it)
ES (1) ES8608528A1 (it)
FI (1) FI79946C (it)
FR (1) FR2555050B1 (it)
GR (1) GR80951B (it)
HU (1) HU193302B (it)
IE (1) IE58130B1 (it)
IL (1) IL73420A (it)
IN (1) IN162717B (it)
IT (1) IT1212900B (it)
LU (1) LU85639A1 (it)
MX (1) MX160792A (it)
NO (1) NO164275C (it)
NZ (1) NZ210091A (it)
PT (1) PT79510B (it)
ZA (1) ZA848776B (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2471776A1 (fr) * 1979-12-21 1981-06-26 Oreal Nouveaux agents cosmetiques a base de polymeres cationiques, compositions cosmetiques les contenant, et leur application
IT1213034B (it) * 1986-02-12 1989-12-07 Istituto Chemioterapico Di Lod Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale.
US5314695A (en) * 1990-11-13 1994-05-24 Corvas International, Inc. Tissue factor based prothrombin time reagent
FR2673512B1 (fr) * 1991-03-05 1993-08-20 Inst Rech Biolog Sa Nouvelles compositions dietetiques a base de lipides complexes phosphores et leur utilisation dans les troubles du sommeil.
IT1247165B (it) * 1991-03-15 1994-12-12 Fidia Spa Uso terapeutico della fosfatidilserina e derivati in patologie degenerative anche associate a disfunsioni immunitarie.
IT1248012B (it) * 1991-06-07 1995-01-05 Mediolanum Farmaceutici Spa Impiego del fosfatidilinositolo per la terapia dei disturbi della depressione.
IT1260149B (it) * 1992-04-17 1996-03-28 Fidia Spa Metodo per la preparazione e purificazione di miscele di fosfolipidi prive di contaminanti da virus non convenzionali
GB9621293D0 (en) * 1996-10-11 1996-11-27 Scotia Holdings Plc Formulations containing unsaturated fatty acids
AU2136501A (en) * 1999-12-10 2001-06-18 Celator Technologies Inc. Lipid carrier compositions with protected surface reactive functions
US7226916B1 (en) * 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
CA2319928A1 (en) * 2000-09-18 2002-03-18 Vasogen Ireland Limited Apoptosis-mimicking synthetic entities and use thereof in medical treatments
TWI281407B (en) * 2000-09-18 2007-05-21 Vasogen Ireland Ltd Apoptosis-mimicking synthetic entities and use thereof in medical treatment
US6676963B1 (en) * 2000-10-27 2004-01-13 Barnes-Jewish Hospital Ligand-targeted emulsions carrying bioactive agents
CN1625406A (zh) * 2001-08-09 2005-06-08 底古萨食品配料有限公司 用于预防和治疗温血动物的应激状态的含有溶血磷脂酰丝氨酸的制剂
JP4599604B2 (ja) * 2002-04-19 2010-12-15 カーギル テクスチュアライジング ソリューションズ ドイチュラント ゲゼルシャフト ミット ベシュレクテル ハフツング ウント コンパニー コマンディートゲゼルシャフト 生体活性のリン脂質含有成分を含有するマトリックス
US6878532B1 (en) 2003-04-28 2005-04-12 Sioux Biochemical, Inc. Method of producing phosphatidylserine
CN1308334C (zh) * 2004-06-01 2007-04-04 山东师范大学 一种从动物脑提取磷脂酰丝氨酸的方法
IL182372A0 (en) * 2007-04-01 2008-01-20 Enzymotec Ltd Compositions containing phosphatidylserine in treating diabetes-associated conditions
ITMI20121784A1 (it) * 2012-10-22 2014-04-23 Velleja Res Srl Composizioni galattogeniche a base di fosfatidilserina
US20160317560A1 (en) * 2013-11-07 2016-11-03 The University Of North Carolina At Chapel Hill Particles containing phospholipids or bioactive fatty acids and uses thereof
IT202100032252A1 (it) * 2021-12-22 2023-06-22 Fidia Farm Spa Processo di estrazione e purificazione industriale di fosfolipidi

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3156616A (en) * 1958-11-14 1964-11-10 Canada Majesty In Right Of Composition and method for correcting foods and blood conditions having clot promoting characteristics
US3436413A (en) * 1965-12-21 1969-04-01 Canada Packers Ltd Process for the isolation of phosphatidyl serine
FR5060M (it) * 1965-12-22 1967-05-08
US4078052A (en) * 1976-06-30 1978-03-07 The United States Of America As Represented By The Secretary Of Health, Education And Welfare Large unilamellar vesicles (LUV) and method of preparing same
JPS55115824A (en) * 1979-02-28 1980-09-06 Nippon Shoji Kk Remedy for clouding of consciousness and sensomobile disorder

Also Published As

Publication number Publication date
DK524884A (da) 1985-05-18
FI79946B (fi) 1989-12-29
FI844468A0 (fi) 1984-11-14
NO164275C (no) 1990-09-19
ZA848776B (en) 1986-06-25
FR2555050A1 (fr) 1985-05-24
AU3563084A (en) 1985-05-30
ATE35415T1 (de) 1988-07-15
IE58130B1 (en) 1993-07-14
PT79510A (en) 1984-12-01
MX160792A (es) 1990-05-17
FR2555050B1 (fr) 1986-12-26
KR850003504A (ko) 1985-06-20
IE842785L (en) 1985-05-17
HUT35957A (en) 1985-08-28
HU193302B (en) 1987-09-28
DE3472406D1 (en) 1988-08-04
CH661734A5 (fr) 1987-08-14
ES8608528A1 (es) 1986-07-16
NO844585L (no) 1985-05-20
FI79946C (fi) 1990-04-10
BE901074A (nl) 1985-05-17
DK524884D0 (da) 1984-11-02
LU85639A1 (fr) 1985-06-04
KR870001330B1 (ko) 1987-07-18
JPS60132921A (ja) 1985-07-16
FI844468L (fi) 1985-05-18
AU572228B2 (en) 1988-05-05
IL73420A (en) 1988-06-30
EP0148045A1 (en) 1985-07-10
NZ210091A (en) 1988-06-30
EP0148045B1 (en) 1988-06-29
JPH0676334B2 (ja) 1994-09-28
IL73420A0 (en) 1985-02-28
ES537575A0 (es) 1986-07-16
IT1212900B (it) 1989-11-30
NO164275B (no) 1990-06-11
IN162717B (it) 1988-07-02
DK168271B1 (da) 1994-03-07
PT79510B (en) 1986-09-08
GR80951B (en) 1984-12-18
US4595680A (en) 1986-06-17

Similar Documents

Publication Publication Date Title
IT8349355A0 (it) Uso terapeutico della fosfatidilserina in malattie del sistema nervoso centrale senza effetti sulla coagulazione sanguigna
DK162986A (da) Terapeutisk middel i enhedsdosisform
DK410787D0 (da) Oralt terapeutisk system med systemisk virkning
DK164632C (da) Engangsfilterpatron
FI872756A (fi) Med laserstraolning fungerande terapeutisk anordning.
IT8522165A0 (it) Vasca da bagno con impianto per idromassaggio perfezionato.
FI880195A0 (fi) Terapeutiska produkter.
IT1182209B (it) Uso terapeutico del monosialoganglioside gm1 e dei suoi derivati in gravi patologie di infarti cerebrali
IT8519418A1 (it) Derivati del 3-metil-imidazo [ 4,5-c] pirazolo con attività terapeutica e procedimento per la loro preparazione
DK250088D0 (da) Ophthalmologisk praeparat
FR2584588B1 (fr) Fauteuil de relaxation
IT1214598B (it) Uso terapeutico della fosfocreatina.
IT8867916A0 (it) Dispositivo per l ossigenazione del sangue
NO173023C (no) Flytende desinfeksjonspreparat
DK42786A (da) Terapivandseng
FR2615369B1 (fr) Chaise-canne
DK38986A (da) Medicinsk inhalationsapparat
IT1203990B (it) Sostanza profilattica e terapeutica per disturbi epatici
KR870000552U (ko) 의자용 캐스터
DK681288D0 (da) Aenootropt terapeutisk laegemiddelae
KR870009940U (ko) 구급차용 의자
KR890013009U (ko) 의자용 캐스터
DK591386D0 (da) Medicinsk apparat
KR880017493U (ko) 맛사지용 가습기
KR890012477U (ko) 보온 의자

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950925